Feed Preview

Autoimmune Disease Therapy

Autoimmune Disease Therapy diagram by undefined

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Top 20 most recent papers
The Lancet Oncology

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet OncologyNovember 27, 2019
Peter SchmidIMpassion130 Investigators
Nature Reviews. Immunology

Treg cell-based therapies: challenges and perspectives

Nature Reviews. ImmunologyDecember 6, 2019
Caroline RaffinJeffrey A. Bluestone
Blood Advances

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Blood AdvancesDecember 4, 2019
Cindy E NeunertSara K Vesely
Cell Metabolism

Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis

Cell MetabolismDecember 3, 2019
Eros MarínAurélie Moreau
Journal of Clinical Medicine

Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study

Journal of Clinical MedicineDecember 2, 2019
Ellen IacobaeusKatarina Le Blanc
JAMA Otolaryngology-- Head & Neck Surgery

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck

JAMA Otolaryngology-- Head & Neck SurgeryDecember 5, 2019
Samantha TamNeil D Gross
Journal of Autoimmunity

Evolving story of autoantibodies in systemic lupus erythematosus

Journal of AutoimmunityDecember 3, 2019
David S Pisetsky
Biochemical and Biophysical Research Communications

Protein C-ets-2 epigenetically suppresses TLRs-induced interleukin 6 production in macrophages

Biochemical and Biophysical Research CommunicationsDecember 3, 2019
Jun ZhaoJi-Feng Feng
Frontiers in Immunology

The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab

Frontiers in ImmunologyNovember 19, 2019
Philippe NicolasRomain Marignier
Journal of Neuroinflammation

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases

Journal of NeuroinflammationNovember 30, 2019
Che SergueraKumaran Deiva
Seminars in Arthritis and Rheumatism

Modulation of bioavailability of proinflammatory cytokines produced by myeloid cells

Seminars in Arthritis and RheumatismNovember 30, 2019
Maxim A NosenkoSergei A. Nedospasov
Frontiers in Immunology

Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells

Frontiers in ImmunologyNovember 7, 2019
Min LianXiong Ma
Current Opinion in Neurology

Ocular myasthenia gravis: updates on an elusive target

Current Opinion in NeurologyNovember 27, 2019
Andrew T MelsonMichael S. Lee
The American Journal of Managed Care

Fostamatinib disodium hexahydrate: a novel treatment for adult immune thrombocytopenia

The American Journal of Managed CareNovember 1, 2019
Ali McBrideAmit R Mehta
Seminars in Arthritis and Rheumatism

Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature

Seminars in Arthritis and RheumatismNovember 16, 2019
Soumya Chatterjee, Richard A Prayson
BMC Biotechnology

Tuning the performance of CAR T cell immunotherapies

BMC BiotechnologyNovember 29, 2019
Noah H RichardsonMarko Z Radic

Emerging Connections of S1P-Metabolizing Enzymes with Host Defense and Immunity During Virus Infections

VirusesNovember 27, 2019
Jennifer J WolfBumsuk Hahm

Interleukin-17 and lupus: enough to be a target? For which patients?

LupusDecember 2, 2019
Marie Robert, Pierre Miossec
Biochemical and Biophysical Research Communications

Intravenous immunoglobulin (IVIg) acts directly on conventional T cells to suppress T cell receptor signaling

Biochemical and Biophysical Research CommunicationsNovember 29, 2019
Ayane HoriSeiji Kawamoto
Frontiers in Cell and Developmental Biology

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients

Frontiers in Cell and Developmental BiologyNovember 15, 2019
Rui-Juan ChengTony N Marion

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

© 2019 Meta ULC. All rights reserved